Tosedostat for elderly acute myeloid leukaemia

Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma

Daratumumab for multiple myeloma

Research provides guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients

Promising new strategy for treating children with acute lymphocytic leukaemia

Comment: Study identifies genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia

Comment: Genetic variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

Engineered cells to target multiple myeloma

Study identifies genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia

Genetic variants for increased risk of osteonecrosis in paediatric acute lymphocytic leukaemia identified

Making the prevention of cancer a routine part of mainstream healthcare

The knock-on effects of breast cancer drugs